Related by context. All words. (Click for frequent words.) 69 metastatic neuroendocrine tumors 68 sorafenib tablets 68 benign prostatic hypertrophy BPH 68 kidney urologic 68 sodium thiosulfate STS 67 YONDELIS 67 Liprotamase 67 ThermoDox R 67 Friedreich Ataxia FRDA 67 prokinetic agent 67 Immunotherapeutic 67 Aviptadil 67 NovaBay Aganocide compounds 67 Zemiva TM 67 QUADRAMET R 67 invasive candidiasis 66 sorafenib Nexavar 66 Vandetanib 66 Cx# [002] 66 reslizumab 66 MAGE A3 ASCI 66 skeletal metastases 66 lexidronam injection 66 IV Busulfex 66 herpetic keratitis 66 monoclonal antibody conjugated 65 essential thrombocythemia ET 65 G#DT 65 mertansine 65 Dacogen decitabine 65 Cancidas 65 Gonal f 65 thalidomide Thalomid 65 Kepivance 65 CINTREDEKIN BESUDOTOX 65 Nexavar sorafenib 65 catheter occlusion 65 malignant ascites 65 benign prostatic hypertrophy 65 neuroendocrine cancers 65 CYT# potent vascular disrupting 65 samarium Sm 65 cIAI 65 Nexavar ® 65 Cetrorelix 65 methylnaltrexone bromide 65 MGd 65 Aflibercept 65 Afatinib 64 Eraxis 64 Wafer polifeprosan 64 oropharyngeal candidiasis 64 Azacitidine 64 MOVIPREP R 64 anti CD3 antibody 64 TNF Tumor Necrosis Factor 64 haematologic malignancies 64 thetreatment 64 rheumatoid arthritis psoriatic arthritis 64 R Saizen R 64 Tamibarotene 64 diarrhea predominant irritable 64 targeted radiotherapeutic 64 FOLOTYN ® 64 Factor VIIa 64 Mitomycin C 64 secondary amenorrhea 64 commercialize deforolimus 64 Onalta TM 64 recurrent NSCLC 64 histone deacetylase inhibitor 64 Sudhir Agrawal D.Phil 64 R sorafenib tablets 64 NAVISTAR R 64 Interferon beta 64 Platinol ® cisplatin 64 Thalomid ® 64 interferon gamma 1b 64 metastatic colorectal 64 Serdolect ® 64 YONDELIS R 64 SIR Spheres 64 microtubule inhibitor 64 pain palliation 64 cisplatin gemcitabine 64 alpha interferons 64 EP #R 64 Solazed TM 64 docetaxel Taxotere ® 64 constipation OIC 63 TEMODAL 63 phase III isavuconazole 63 Bayer Nexavar 63 overactive bladder syndrome 63 Noxafil 63 urothelial cancer 63 toenail onychomycosis 63 Cloretazine 63 hematological disorders 63 Homspera TM 63 prescription laxative 63 sJIA 63 acetonide FA 63 Lubiprostone 63 EOquin TM 63 hyperphenylalaninemia HPA due 63 erlotinib Tarceva ® 63 levocetirizine 63 Neulasta R 63 treat chronic sinusitis 63 AFRS TM 63 immuno modulatory 63 investigational monoclonal antibody 63 IL# PE 63 Pyridorin 63 radiotherapeutic 63 efalizumab 63 relapsed MM 63 micafungin 63 hypervascular tumors 63 CellCept mycophenolate mofetil 63 Hepatocellular Carcinoma 63 Sebivo 63 TheraCIM 63 Evoltra ® 63 lymphomas leukemias 63 immunotherapeutic vaccine 63 Insegia 63 Certican 63 chronic thromboembolic pulmonary 63 pregabalin Lyrica 63 colorectal lung 63 metastatic GIST 63 humanized monoclonal 63 Peginterferon alfa 2b 63 recombinant interferon 63 topical formulations 63 Neulasta ® 63 Amplimexon 63 Certolizumab pegol 63 microsphere therapy 63 hematological diseases 63 trabectedin 63 bortezomib Velcade 63 etanercept Enbrel 63 complement inhibitor eculizumab 63 bladder ovarian 63 RECOTHROM R 63 derivatives Radilex TM 63 fluoroquinolone antibiotic 63 ADP receptor antagonist 63 Potelligent Technology 63 dihydrochloride 63 bevacizumab Avastin ® 63 metastatic malignant 63 treat menorrhagia 63 uricase 63 Irinotecan 63 Azathioprine 63 either acutely decompensated 63 LHRH receptor positive 63 polycythemia vera PV 63 Selective Internal 63 Prodarsan R 63 Sporanox 63 ergot derivatives 63 sodium stibogluconate 63 prasterone 63 immunological diseases 63 pancreatic enzyme replacement 63 Cethrin R 63 Proellex TM 63 Initiate Clinical Trial 63 treating cancerous tumors 63 LHRH antagonist 63 Collategene 63 candidates Azedra TM 63 GW# [003] 63 TELINTRA 63 Nexavar sorafenib tablets 63 CTAP# Capsules 62 FS Antihemophilic Factor Recombinant 62 Fondaparinux 62 Leukine ® 62 Recombinant Human 62 Pemetrexed 62 Mestinon 62 Tarceva TM 62 vaginal candidiasis 62 symptomatic benign prostatic 62 novel VDA molecule 62 refractory prostate cancer 62 Phase #b/#a clinical 62 hepatitis C HCV 62 LEUKINE 62 Bazedoxifene 62 anti infective treatments 62 Patients Treated With 62 SNT MC# 62 lung pancreatic 62 Degarelix 62 Dapagliflozin 62 Perforomist ™ Inhalation Solution 62 RELOVAIR ™ 62 Tigecycline 62 Rebif ® 62 SYCREST 62 esophageal candidiasis 62 commercialize elagolix 62 Ixempra 62 Methylnaltrexone 62 Fabry Disease 62 Alemtuzumab 62 Initiates Clinical Trial 62 PDX pralatrexate 62 IMiDs ® compound 62 Temodar ® 62 forodesine 62 Mitoxantrone 62 Gemzar ® 62 Taxotere docetaxel 62 refractory chronic lymphocytic 62 BENLYSTA ® 62 myeloproliferative diseases 62 oncologic diseases 62 hematologic disorders 62 Silodosin 62 Daclizumab 62 RhuDex ® 62 Hsp# Inhibitor 62 including eniluracil ADH 62 synthetic retinoid 62 Squalamine 62 Golimumab 62 chemotherapy induced neutropenia 62 Allovectin 7 ® 62 Epidermal Growth Factor Receptor 62 quinolone antibiotic 62 metastatic gastric 62 oxaliplatin Eloxatin 62 Complicated Skin 62 Vaprisol 62 myelofibrosis polycythemia vera 62 NEUMUNE 62 SinuNase TM 62 riociguat 62 Gliadel Wafer 62 Zavesca R 62 PSMA ADC 62 ocular formulation 62 Canvaxin 62 SPRYCEL ® 62 IMiDs R 62 recombinant FVIII 62 CTAP# 62 Onconase 62 histone deacetylase HDAC inhibitor 62 unresectable tumors 62 gastrointestinal disorders ATI 62 acyclovir Lauriad R 62 oropharyngeal candidiasis OPC 62 malignant neoplasms 62 Selective Electrochemical Tumor Ablation 62 Bendamustine 62 eprotirome 62 adenomatous 62 alkylating agent 62 Lenocta 62 aripiprazole Abilify 62 chronic myocardial ischemia 62 Calcitonin 62 radiolabeled TM# 62 Tacrolimus 62 lymphoid malignancies 62 GTC recombinant human 62 acute HAE attacks 62 Campto 62 aspirin clopidogrel 62 refractory gout 62 oncology indications 62 Kit CD# positive 62 haematological malignancies 62 goserelin 62 Xcytrin R 62 Civacir 62 Surgical resection 62 small molecule thrombopoietin 62 volociximab 62 Amrubicin 62 lucinactant 62 candidemia 62 INCB# [003] 62 Eculizumab 62 sulodexide 62 biliary tract cancer 62 pancreatic prostate 62 Allovectin 7 62 TheraCIM h R3 62 ARIXTRA R 62 Soliris eculizumab 62 alvespimycin 62 cystic fibrosis chronic pancreatitis 62 IL# PE#QQR 62 pan HDAC inhibitor 62 Li Fraumeni Syndrome 62 tiuxetan 62 induced macular edema 62 superficial basal cell carcinoma 62 erythematosus 62 docetaxel Taxotere R 62 Known generically 62 sargramostim 62 Tykerb lapatinib 62 severe malignant osteopetrosis 62 ZACTIMA 62 PNP inhibitor 62 Zentaris 62 proteasome inhibitor 62 psoriasis Crohn disease 62 anticancer treatments 62 Tambocor 62 GnRH agonists 62 Lambert Eaton Myasthenic 62 Hycamtin 62 Vidaza azacitidine 62 Hexvix ® 62 VISICOL R 62 OMNARIS HFA 62 DDP# 62 Transdermal Patch 61 myeloproliferative disorders 61 Taiho Pharmaceutical 61 relapsed ovarian cancer 61 Hepatocellular Carcinoma HCC 61 IgG1 monoclonal antibody 61 Syndrome LEMS 61 Torisel temsirolimus 61 refractory acute myeloid 61 subependymal giant cell 61 cardio renal 61 HQK 61 Fluconazole 61 Tarceva erlotinib 61 LibiGel ® 61 HeFH 61 INTEGRILIN ® 61 Hematological 61 OvaRex ® MAb 61 trastuzumab DM1 61 breast pancreatic 61 novel oral anticoagulant 61 Cellegesic 61 Aloxi ® 61 Caelyx 61 INSPIRE Trial Phase III 61 HepaGam B TM 61 coronary stent merged 61 gemcitabine Gemzar 61 refractory APL 61 Kissei Pharmaceutical 61 Gemzar gemcitabine 61 Fludara ® 61 venous stasis ulcers 61 thrombolytic agent 61 cutaneous T 61 Combination REOLYSIN R 61 treat enlarged prostate 61 THALOMID R 61 pediatric Crohn disease 61 Oracea TM 61 Squamous 61 IMiDs ® 61 Oxaliplatin 61 transthyretin TTR mediated amyloidosis 61 tuberous sclerosis TS 61 terlipressin 61 acadesine 61 chemotherapy cisplatin 61 Mycamine 61 Cimzia TM 61 Onalta ™ 61 inhibitor RG# 61 Rilonacept 61 chronic ITP patients 61 Topical Solution 61 DepoDur 61 investigational compounds 61 GVAX ® 61 Dalbavancin 61 investigational humanized monoclonal antibody 61 bevacizumab Avastin 61 Androxal TM 61 gefitinib Iressa 61 Cimzia ® certolizumab pegol 61 NAGS deficiency 61 DIABECELL 61 transthyretin amyloidosis 61 papillary renal cell carcinoma 61 intra abdominal infections 61 Investigational Treatment 61 embolotherapy 61 mesylate 61 humanized monoclonal antibodies 61 Asthma COPD 61 JAK inhibitor 61 Zorbtive TM 61 Telatinib 61 ospemifene 61 bendamustine HCl 61 eflornithine 61 PEGINTRON TM 61 CONBRIZA 61 Paraplatin ® 61 Gefitinib 61 orally administered inhibitor 61 rFactor XIII 61 ACTEMRA TM 61 GERD migraine headaches 61 vinca alkaloid 61 pioglitazone HCl 61 headache abdominal pain 61 sunitinib Sutent 61 Orally administered 61 Velcade bortezomib 61 Tasimelteon 61 gastrointestinal cancers 61 Yondelis ® 61 rhITF 61 pemetrexed Alimta 61 Trofex 61 PEGylated anti 61 aerosolized AAT 61 antiemetics 61 ALN PCS 61 pegylated liposomal doxorubicin 61 Anidulafungin 61 HP Acthar Gel repository 61 fusion enhancers 61 Mimpara 61 humanised monoclonal antibody 61 anthracycline taxane 61 rasagiline tablets 61 Adult Stem Cell Therapy 61 MYLOTARG 61 MKC# MT 61 BCG refractory 61 metaglidasen 61 direct renin inhibition 61 ophthalmology dermatology 61 thymosin beta 4 61 Nexavar tablets 61 Vidaza ® 61 trastuzumab DM1 T DM1 61 psoriasis rheumatoid arthritis 61 Azedra 61 Chronic Prostatitis 61 lanreotide 61 SUPPRELIN R LA 61 oxypurinol 61 oncolytic virus therapies 61 depsipeptide 61 Prochymal TM 61 Pathway Inhibitor 61 p# biomarker 61 RoACTEMRA 61 Apaziquone 61 Granulocyte Colony Stimulating Factor 61 hormone agonist 61 Personalized Immunotherapy 61 Alinia 61 AEG# 61 Procoralan 61 photodynamic treatment 61 cyclophilin inhibitors 61 Neupogen ® 61 paclitaxel cisplatin 61 Toraymyxin 61 dirucotide MBP# 61 ovarian breast 61 recurrent glioblastoma multiforme 61 hypereosinophilic syndrome 61 immune modulatory 61 clobazam 61 kallikrein 61 CTEPH 61 Accelerated Partial Breast Irradiation 61 busulfan 61 trastuzumab Herceptin R 61 gastrointestinal mucositis 61 Panzem 61 Systemic lupus erythematosus 61 prostanoid 61 dermatological disorders 61 BrachySil TM 61 PROSTASCINT R 61 Pegloticase 61 Warfarin Coumadin 61 calcineurin inhibitors 61 tigecycline 61 Pegasys peginterferon alfa 2a 61 Plasmin 61 beta lactam antibiotic 61 Mg Uk 61 systemic fungal infections 61 nonmelanoma skin cancers 61 investigational pharmacologically unique 61 Prolongs Survival 61 Zometa zoledronic acid 61 Benign Prostatic Hyperplasia 61 dasatinib Sprycel 61 Juvenile Idiopathic Arthritis JIA 61 preclinical efficacy 61 Actimmune ® 61 non resectable metastatic 61 Aryplase 61 antitumor effect 61 immunodeficiency disorders 61 GRNCM1 61 amifostine 61 huC# DM4 61 Maribavir 61 tamoxifen citrate 60 LEP ETU 60 Navelbine ® 60 Plaquenil 60 Xyfid TM 60 Tocilizumab 60 Reports Preclinical Data 60 arteriovenous malformations 60 Trofex TM 60 Gleevec Glivec 60 Cetuximab Erbitux 60 Myelodysplastic syndromes MDS 60 Genentech Rituxan 60 Aganocide ® 60 ELACYT 60 Initiates Enrollment 60 cryptococcosis 60 Levoleucovorin 60 Panzem R 60 OHR/AVR# 60 Zenapax 60 Chronic Heart Failure 60 vitreoretinal disorders 60 Zemiva ™ 60 Myocet 60 Medullary thyroid cancer 60 neratinib 60 Diabetic Macular Edema 60 Pazopanib 60 Angiolix 60 neoplastic diseases 60 endometrial hyperplasia 60 novel immunotherapies 60 Prostatitis 60 Gleevec resistant 60 histamine dihydrochloride 60 rituximab Rituxan 60 Danazol 60 meropenem 60 pertuzumab 60 KL4 Surfactant 60 cetuximab Erbitux 60 ALN HPN 60 radionuclide therapy 60 Myolimus 60 antisense inhibitors 60 AZILECT ® 60 steroid refractory 60 ONCASPAR 60 advanced hepatocellular carcinoma 60 immunotherapeutic approaches 60 Tekamlo 60 RNAi therapeutic targeting 60 Cellcept 60 cidofovir 60 Diabetic Neuropathy 60 liposomal formulation 60 tranilast 60 immunotoxins 60 alefacept 60 CTLA4 Ig 60 Gilead Viread 60 Teysuno 60 Aganocide 60 FluCAM arm 60 adult chronic ITP 60 antithrombotics 60 Renal Cell Carcinoma RCC 60 PGL# 60 stem cell transplantations 60 adult mesenchymal stem 60 OZURDEX ® 60 Proquin XR 60 intravesical instillation 60 GA GCB 60 Adenuric R 60 Onalta 60 vascular insufficiency 60 PROCHYMAL 60 Ethyol 60 noninfectious uveitis 60 inflammatory autoimmune diseases 60 pancreatic ovarian 60 TheraSphere 60 iobenguane 60 relapsing remitting MS RRMS 60 PrevOnco 60 Nimotuzumab 60 hyperplasia BPH 60 diagnostic molecular imaging 60 infliximab Remicade 60 HepaGam B 60 intravenous acetaminophen 60 miconazole Lauriad ® 60 Overactive Bladder 60 thromboembolic disease 60 delay bone metastases 60 Litx 60 oral prodrug 60 Aplidin 60 Romiplostim 60 Taxotere chemotherapy 60 mycosis fungoides 60 cilengitide 60 lenalidomide Revlimid R 60 Cyclosporin 60 Alkeran 60 luliconazole 60 XIAFLEX ® 60 PHX# 60 anticancer compound 60 Galantamine 60 Sanofi Aventis Taxotere 60 Pertuzumab 60 Abstract Accepted 60 Altastaph 60 fallopian tube carcinoma 60 CEQ# 60 Prostacyclin 60 relapsed leukemia 60 Candida infection 60 GI motility disorders 60 Prodarsan ® 60 hormone refractory metastatic prostate 60 mitogen activated ERK kinase 60 cutaneous lupus 60 Actinic Keratosis 60 Viprovex TM 60 Gemcitabine 60 interferon alfa 2b 60 #I TM# 60 LPM TM 60 hormone LHRH antagonist 60 antiarrhythmic drug 60 rhIGF-I/rhIGFBP-3 60 unoprostone isopropyl 60 venous thromboembolic events 60 metastatic bladder 60 Vicinium TM 60 DCVax R Brain 60 Cypher Sirolimus 60 PD LID 60 ticagrelor Brilinta 60 receptor tyrosine kinase inhibitor 60 Zolinza 60 Ischemic 60 NP2 Enkephalin 60 ARCOXIA 60 idiopathic thrombocytopenic purpura ITP 60 cMET 60 coagulation disorders 60 antiplatelet agent 60 Arimidex anastrozole 60 advanced metastatic renal 60 Systemic Lupus Erythematosus SLE 60 imiquimod cream 60 cysteamine bitartrate 60 rxRNA 60 prostone 60 incyclinide 60 AQ4N 60 evaluating tivozanib 60 sublingual tablets 60 Clindesse 60 Luteinizing Hormone Releasing Hormone 60 Seikagaku 60 A1PI 60 secondary hyperparathyroidism 60 JAK inhibitors 60 Increlex R 60 Inhalation Solution 60 chronic eosinophilic leukemia 60 Mycophenolate Mofetil 60 PrevOnco ™ 60 Orphan Status 60 Gonal f R 60 casopitant 60 DEFLUX 60 REVLIMID R 60 Bezielle 60 urethral bulking agent 60 novel peptide 60 vidofludimus 60 oral mTOR inhibitor 60 teriflunomide 60 Progenta TM 60 intravenous immunoglobulin 60 acute decompensated heart 60 Roche Xeloda 60 nosocomial pneumonia 60 CIPN 60 uterine fibroid 60 hoFH 60 colorectal pancreatic 60 Genasense ® 60 immune modulator 60 mTOR inhibitors 60 Novantrone R 60 targeted antifolate 60 pouchitis 60 Vascugel 60 GRASPA ® 60 Myelofibrosis 60 Somatuline 60 paroxysmal nocturnal hemoglobinuria 60 Dacogen injection 60 G6PD deficiency 60 UPLYSO 60 dermatological indications 60 FASLODEX 60 IAP inhibitors 60 NeuroSTAT ® 60 SEBIVO 60 benign neoplasms 60 5 fluorouracil leucovorin 60 aflibercept VEGF Trap 60 docetaxel Taxotere 60 immunomodulatory therapy 60 adalimumab Humira 60 DURIN TM 60 HuMax EGFr 60 CIMZIA ™ 60 Removab 60 MTP inhibitor 60 Campath ® 60 mTOR mammalian target 60 mechanical thrombectomy 60 AKT inhibitor 60 Oxypurinol 60 Multiferon R 60 TTR amyloidosis 60 recurrent metastatic 60 Solaraze 60 lintuzumab SGN 60 transplantation HCT 60 novel emulsion formulation 60 Clolar ® 60 post herpetic neuralgia PHN 60 Pivotal Phase III 60 Ophena 60 Arranon 60 Archexin 60 Monoclonal antibody 60 PRT# 60 Atypical Hemolytic Uremic Syndrome 60 biotherapy 60 Safinamide 60 abnormal uterine bleeding 60 Trabectedin 60 Epirubicin 60 Olmesartan 60 adipose tissue derived 60 Panzem R NCD 60 antifungal agent 60 Fosphenytoin 60 TNF blocker 60 fluoropyrimidine 60 multi kinase inhibitor 60 Kissei 60 TRIOLEX HE# APOPTONE HE# 60 Provectus Pharmaceuticals specializes 60 R bendamustine hydrochloride 60 HER2 positive metastatic breast 60 cediranib 60 Receives Orphan Drug Designation 60 Interferon alpha 60 Eltrombopag 60 rufinamide 60 TRISENOX ® 60 malignant pleural mesothelioma 60 5 FU leucovorin 60 anti angiogenic agents 60 delafloxacin 60 VEGF inhibitors 60 radiation sensitizer 60 multiple myeloma MM 59 intranasal delivery 59 ATL# [002] 59 Pirfenidone 59 STRIDE PD 59 albumin bound paclitaxel 59 Triapine 59 TYZEKA 59 lenalidomide dexamethasone 59 arthritis PsA 59 Ecallantide 59 symptomatic BPH 59 Pemphigus 59 basiliximab 59 Initiates Phase II 59 Electronic Brachytherapy System 59 TransMID TM 59 FUSILEV ® 59 FDA APPROVES 59 Serostim ® 59 R vitespen 59 Microplasmin 59 Copegus ribavirin 59 TREANDA 59 Basal Cell 59 topical antifungal 59 trospium 59 2 inhibitor CYT# 59 Chronic lymphocytic leukemia 59 sitaxsentan 59 Dasatinib 59 Benign Prostatic Hyperplasia BPH 59 systemic immunosuppressive drugs 59 colorectal carcinoma 59 mitoxantrone concentrate 59 targeting Inflammatory Bowel 59 Natalizumab 59 BioNumerik 59 drug ISA# 59 cannabinor 59 udenafil 59 panitumumab Vectibix 59 Everolimus 59 Xanafide 59 Presents Preclinical 59 IMiDs 59 Busulfex 59 Ophena TM 59 Raptiva R 59 gastrointestinal stromal tumors GIST 59 MEK inhibitors 59 INS# [001] 59 Completes Patient Enrollment 59 Thrombin 59 telomerase activators 59 TransVax ™ 59 Faropenem 59 gastro intestinal inflammation 59 ALN TTR# 59 Zalypsis 59 Interferon alfa 59 recombinant factor VIIa 59 SUTENT ® 59 calcineurin inhibitor 59 MyVax R 59 adenosine injection 59 ChronVac C R 59 TRISENOX 59 liposomal amphotericin B 59 Allergic Rhinitis 59 See CLINICAL PHARMACOLOGY 59 anti amnesic 59 Tß4 59 Sezary syndrome 59 neuro developmental disorders 59 TNF alpha antagonist 59 Iressa gefitinib 59 zoledronic acid Zometa 59 tubulin inhibitor 59 Neo Bladder Augment 59 Ozurdex 59 demethylating agent 59 Lymphoid 59 Generx TM 59 Uvidem 59 Bucindolol 59 Nilotinib 59 Shigamabs ® 59 Severe Primary IGFD 59 systemic juvenile idiopathic 59 peritoneal carcinomatosis 59 Bicalutamide 59 chronic granulomatous disease 59 PI3K/Akt pathway inhibitor 59 ovarian prostate 59 Acute Radiation Syndrome ARS 59 Pfizer Sutent 59 mapatumumab 59 SinuNase ™ 59 dihydrochloride Tablets 59 Vitaxin 59 glucocorticoid induced osteoporosis 59 BR.# 59 antiretroviral medicinal 59 Successfully Treats 59 Ribavirin causes 59 Hematologic 59 2 methoxyestradiol 59 Exelon rivastigmine 59 ara C 59 opioid induced constipation OIC 59 COLAZAL R 59 targeted radiotherapeutics 59 liposome encapsulated 59 Allogeneic 59 somatostatin analogues 59 allogeneic hematopoietic stem cell 59 lapatinib Tykerb 59 invasive aspergillosis 59 KL4 surfactant 59 oral salmon calcitonin 59 rheumatoid arthritis osteoarthritis ankylosing 59 Phase III Clinical Trial 59 SNT-MC#/idebenone 59 sacral nerve stimulation 59 EC Cysteamine 59 Increlex ® 59 letrozole Femara 59 refractory CLL 59 Marketing Authorization Applications 59 anastrazole 59 PORxin TM platforms 59 Luveris R Ovidrel R 59 hypoxia activated prodrug 59 Zavesca r 59 carcinoid tumors 59 ZOLINZA 59 refractory acute promyelocytic 59 opioid induced bowel dysfunction 59 RECOTHROM ® 59 cancer mCRC 59 Traficet EN 59 immunodeficiencies 59 Thrombin topical Recombinant 59 Dupuytren Contracture 59 rheumatoid arthritis juvenile idiopathic 59 Fenofibrate 59 Mucositis 59 Receives Orphan Drug 59 Wellstat 59 Prosaptide 59 amrubicin 59 Vidaza R 59 Investigational Compound 59 cinacalcet HCl 59 idiopathic myelofibrosis 59 Ranolazine 59 HuMax CD4 59 TLR antagonists 59 cleavable linker 59 basal cell carcinoma BCC 59 thymectomy 59 superficial bladder cancer 59 Kaketsuken 59 Nalmefene 59 gastrointestinal stromal tumors GISTs 59 TÎ ² 4 59 Combidex 59 ularitide 59 EndoTAG 59 XOPENEX R 59 BCR ABL inhibitor 59 interleukin IL -# 59 MVA BN 59 Tectin TM 59 Myelodysplastic Syndromes 59 TORISEL 59 Topical corticosteroids 59 Antisense Pharma GmbH 59 Cariprazine 59 visilizumab 59 leukemia AML 59 inhaled AAT 59 SIR Spheres microspheres 59 Trandolapril 59 MEK inhibitor 59 LC#m# 59 transurethral 59 Anthracycline 59 HepaLife TM 59 Modrenal R 59 Luveris 59 palliative radiotherapy 59 APTIVUS R 59 Moxifloxacin 59 Systemic lupus erythematosus SLE 59 REMICADE ® 59 Clinical Trial Results 59 Proxinium TM 59 isoform selective 59 Entereg R 59 Eloxatin ® 59 HyperAcute